Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00164177|
Recruitment Status : Completed
First Posted : September 14, 2005
Last Update Posted : February 7, 2013
|Condition or disease||Intervention/treatment||Phase|
|Colonoscopy||Drug: HalfLytely||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Preliminary Evaluation Of The Efficacy Of HalfLYTELY® For Bowel Cleansing Before Virtual Colonoscopy (VC) and Conventional Colonoscopy (CC).|
|Study Start Date :||October 2004|
|Actual Primary Completion Date :||December 2004|
- Efficacy of the preparation to produce a degree of fecal matter and residual liquid that would not interfere with VC or CC.
- Incidence of adverse events.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00164177
|United States, Florida|
|Vero Beach, Florida, United States, 32960|
|Principal Investigator:||H. Paul Hatten, Jr., MD||Indian River Radiology|